federal service for surveillance on consumer rights protection … · 2012. 10. 19. · crs...

Surveillance for rubella,

rubella in pregnant women and CRS

in the Russian Federation

TSVIRKUN OLGAV. MD PhD NSMC for measales and rubella surveillance

Italy, Rome

8-10 February 2012

Federal Service for Surveillance on

Consumer Rights Protection and Wellbeing

Years 1st dose 2nd dose Supplemental

immunization

1997-2000 12 months of age

6 years of age

--

2001-2006 12 months

6 years for 13 year old, who had no rubella and were not vaccinated or had one dose only

2006-2007. The additional immunization within the National project Health when 17 million children under 14 years of age and young women aged 17-25 years were vaccinated

2007-2010 12 months

6 years for 1-17 year old who had no rubella and were not vaccinated or had one dose only;

for young women aged 18-25 years

2011 12 months 6 years for 1-18 year olds who had no rubella and were not vaccinated or had one dose only;

for young women aged 18-25 years

12.7%

69.7%

82.0% 82.8%

67.9%

93.6% 95.4% 96.1% 96.6% 96.4% 97.0%

6.3% 7.6% 11.0% 8.4%

15.4%

45.0%

85.4% 92.7%

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

100.0%

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010

проценты

Годы

V1 год R 6 лет

Distribution of the Russian Federation’s territories according to the rubella incidence

Cases/ 100 000

population

Number of territories

2009

2010 2011

0 25 22 48

<1 41 55 33

1-3 14 6

1

3,1-5 3 - 1

> 5,1 - - -

Under 1 year 1-2 year 3-6 years 7-14 years

76.7

16.2

2.32 0.55

14.1

2.3 0.32 0.05 0

10

20

30

40

50

60

70

80

90

2008 2009 2010 2011

Cas

es

/10

0 0

00

po

pu

lati

on

годы

Заболеваемость краснухой в РФ среди детей с 2008 по 2011гг

до 1 года 1-2 года

3-6 лет 7-14 лет

Rubella incidence in children in the Russian

Federation, 2008-2011

years

Under 1 year year

year year

Years Number of children with CRS

Incidence per 1000 live births

2000 11 0,01

2001 7 0,005

2002 6 0,005

2003 2 0,002

2004 2 0,002

2005 2 0,002

2006 10 0,01

2007 8 0,01

2008 5 0,003

2009 1 0,001

2010 1 0,001

2011 0 0

Cases/ 1 000 000 population

0

0…1

1…5

5…10

10…20

Ufa 1Н(3)

2B(1)

Rostov 1Н(2)

Saratov 1Н(2)

Mariy El Н(1)

Riazan 1Н(2)

Voronezh 1Н(3) Cheliabinsk

1Н(1)

Penza 1Н(4)

Omsk 1Н(3)

Lipetsk 1Н(4)

Nizhny

Novgorod

1Н(1)

Stavropol

1Н(1), 1E(1)

Volgograd

1Н(3) Samara 1Н(1)

Belgorod

1Н(1)

Incidence and virus genotypes of rubella in Russian Federation

11

Introduction of recording of rubella cases by age, vaccination status, number of foci and secondary spread from 2008;

Introduction of rubella surveillance for pregnant women with compulsory

laboratory follow-up from 2008;

Case based reporting and investigation of rubella cases in pregnant women from 2008;

Detection of contact pregnant women in confirmed foci; Collection of clinical samples for genetic characterization of rubella virus

from all Russian Federation regions from 2006;

Integration of rubella surveillance into the existing measles surveillance laboratory network from 2008;

Implementation of case based rubella surveillance at the national level with

compulsory laboratory verification from 2012.

Presence of marginalized groups in the population

(gypsies, forced migrants, religious communities);

Insufficient vaccination coverage in groups that are exposed to professional risk of infection;

Refusals from vaccination at some population groups.

To sustain high measles and rubella vaccination coverage (no less than 90-95%) with first and second doses in target groups of the population in all territories of the Russian Federation;

To introduce case based registration of rubella cases in the information system CISID which is also used for measles registration;

To ensure no less than 90% of compulsory laboratory confirmation for rubella cases;

To carry out targeted activities aimed at informing the population about the importance of measles and rubella prevention;

To train and re-train regularly specialists of practical health care in issues of diagnostics, clinical picture, epidemiology and prevention of measles, rubella and CRS.